When Is Glaucoma Surgery Needed?

Glaucoma is a progressive eye condition that damages the optic nerve, the structure responsible for carrying visual information from your eye to your brain. While many patients manage glaucoma effectively with eye drops or laser procedures, there are times when surgery becomes the most appropriate next step to protect your remaining vision. At Greenwich Ophthalmology Associates, our glaucoma specialists work with patients across the greater NY/CT region to determine the right timing for surgical intervention based on each individual's disease severity, treatment response, and long-term goals. Understanding when and why surgery is recommended can help you feel confident and informed if that conversation arises during your care.

Surgery is typically considered when other treatments are no longer controlling your eye pressure or preventing further damage to the optic nerve. Several clinical indicators help our glaucoma specialists determine whether it is time to transition from medical or laser therapy to a surgical approach.

The most common reason for recommending surgery is intraocular pressure (IOP) that remains above your target level despite maximum tolerated medication and laser treatment. Every patient has a unique target pressure, which is the level your doctor believes will slow or stop further optic nerve damage. When your IOP consistently stays above that target, the risk of ongoing vision loss increases, and surgery may offer a more reliable way to bring pressure down.

Even if your eye pressure appears reasonable on individual readings, your doctor may recommend surgery if testing shows that your glaucoma is getting worse. Progression is typically identified through changes on optical coherence tomography (OCT) scans, which measure the thickness of the nerve fiber layer, or through worsening results on visual field tests that map your peripheral vision. If these tests reveal a pattern of decline over multiple visits, surgery may be necessary to reach a lower pressure and slow the rate of damage.

Some patients experience side effects from glaucoma eye drops that make long-term use difficult. Redness, stinging, fatigue, breathing changes, or allergic reactions can all interfere with consistent use. Others may have difficulty instilling drops on a daily schedule due to physical limitations or complex regimens. In these situations, surgery can provide pressure reduction that does not depend on daily medication compliance.

Patients diagnosed with advanced glaucoma or those whose disease is progressing rapidly may benefit from earlier surgical intervention rather than a prolonged trial of drops and laser. When significant vision has already been lost or the rate of progression threatens functional vision within a patient's lifetime, our glaucoma specialists may recommend surgery sooner to achieve a very low target pressure and preserve what remains.

Several surgical options exist for glaucoma, each designed to lower intraocular pressure through a different mechanism. The choice depends on your type of glaucoma, its severity, your anatomy, and your overall eye health.

Trabeculectomy is one of the most established and effective surgical procedures for glaucoma. During this operation, the surgeon creates a small flap in the white of the eye (sclera) that allows fluid to drain from inside the eye into a small reservoir called a bleb, which forms beneath the conjunctiva. The bleb is hidden under the upper eyelid and gradually absorbs the fluid. Trabeculectomy can achieve very low postoperative pressures, making it particularly useful for patients with advanced glaucoma or normal-tension glaucoma who need aggressive pressure reduction.

Tube shunt surgery, also known as aqueous shunt or glaucoma drainage device implantation, involves placing a small silicone tube connected to a plate reservoir on the surface of the eye. The tube redirects fluid from the anterior chamber to the plate, where it is absorbed by surrounding tissue. Common devices include the Ahmed valve, which has a built-in flow restrictor, and the Baerveldt implant, which does not. Tube shunts are often recommended for patients with secondary glaucoma, those who have had a prior failed trabeculectomy, or cases where conjunctival scarring limits other surgical options.

MIGS encompasses a group of procedures that use tiny devices or controlled tissue removal to enhance the eye's natural drainage pathways. Examples include the iStent, Hydrus Microstent, and XEN Gel Stent, as well as angle-based procedures like goniotomy and trabecular bypass. Many MIGS procedures can be performed at the same time as cataract surgery, offering the convenience of addressing both conditions in one session. The trade-off is that MIGS procedures generally produce a more modest pressure reduction compared to trabeculectomy or tube shunt surgery.

Cyclophotocoagulation (CPC) takes a different approach by reducing the amount of fluid the eye produces rather than improving drainage. The procedure uses laser energy to treat the ciliary body, the structure responsible for making aqueous humor. Micropulse CPC is a newer, gentler version that delivers energy in short bursts, reducing the risk of complications compared to older continuous-wave techniques. CPC can be appropriate for patients with refractory glaucoma or those who are not good candidates for other incisional procedures.